Bausch & Lomb Corp: directors' dealings · United States · SEC (Form 4) SEC:bausch-and-lomb-corp-f13113 US US · SEC (Form 4) Mcap 5.7Bn€ Healthcare
Explore the full insider trade history of Bausch & Lomb Corp, a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Healthcare sector, Bausch & Lomb Corp has published 17 public disclosures. Market capitalisation: €5.7bn. The latest transaction was disclosed on 30 June 2022 — Attribution. Among the most active insiders: Bausch Health Companies Inc.. Every trade is free.
Financial data FY ended December 2025 · cache
Analyst consensus
13 analysts 16.00 € Target 18.04 €(+12%) 21.00 €
Income statement
Revenue 5.10 Bn€
Gross profit 3.05 Bn€ 60% margin
Net income −360.0 M€ -4.2% margin
Valuation
PER (forward) 15.1x
P/Book 0.9x
Beta 0.59
Balance sheet & cash
Market cap 5.74 Bn€
Total debt 5.08 Bn€
Free Cash Flow −66.0 M€
Debt / Equity 79%
Profitability & ownership
ROE -3.3%
ROA 1.4%
% insiders 87.6%
% institutions 11.0%
Last declaration on 30 June 2022
Declarations 17 total
Executives ◆ Grant14 SEC
013,256 shares 0
Common Shares, No Par Value
SEC:0001127602-22-018300:0 · 28 Jun 2022
Executives ◆ Grant14 SEC
013,256 shares 0
Common Shares, No Par Value
SEC:0001127602-22-018298:0 · 28 Jun 2022
Executives ▼ Sale19 SEC
€73m 4,550,357 shares @ €16.0078 1.27% mcap 11.4% of flow
Common Shares, No Par Value
SEC:0000899243-22-020663:0 · 1 Jun 2022
Executives ◆ Grant14 SEC
012,500 shares 0
Common Shares, No Par Value
SEC:0000899243-22-017859:0 · 10 May 2022
Executives ◆ Grant14 SEC
012,500 shares 0
Common Shares, No Par Value
SEC:0000899243-22-017847:0 · 10 May 2022
Executives ◆ Grant14 SEC
012,500 shares 0
Common Shares, No Par Value
SEC:0000899243-22-017855:0 · 10 May 2022
Executives ▼ Sale29 SEC
€567m 35,000,000 shares @ €16.192 9.88% mcap 88.6% of flow
Common Shares, No Par Value
SEC:0000899243-22-017761:0 · 10 May 2022
Executives ◆ Grant14 SEC
012,500 shares 0
Common Shares, No Par Value
SEC:0000899243-22-017854:0 · 10 May 2022
Executives ◆ Grant14 SEC
012,500 shares 0
Common Shares, No Par Value
SEC:0000899243-22-017852:0 · 10 May 2022
Executives ◆ Grant14 SEC
012,500 shares 0
Common Shares, No Par Value
SEC:0000899243-22-017858:0 · 10 May 2022
Executives ◆ Grant14 SEC
012,500 shares 0
Common Shares, No Par Value
SEC:0000899243-22-017853:0 · 10 May 2022
Executives ◆ Grant5 SEC
069,444 shares 0
Common Shares, No Par Value
SEC:0000899243-22-017323:0 · 5 May 2022
Executives ◆ Grant14 SEC
034,722 shares 0
Common Shares, No Par Value
SEC:0000899243-22-017317:0 · 5 May 2022
Executives ◆ Grant22 SEC
0125,000 shares 0
Common Shares, No Par Value
SEC:0000899243-22-017319:0 · 5 May 2022
Executives ◆ Grant14 SEC
022,222 shares 0
Common Shares, No Par Value
SEC:0000899243-22-017322:0 · 5 May 2022
Executives ◆ Grant25 SEC
0472,222 shares 0
Common Shares, No Par Value
SEC:0000899243-22-017320:0 · 5 May 2022
Executives ◆ Grant5 SEC
083,333 shares 0
Common Shares, No Par Value
SEC:0000899243-22-017321:0 · 5 May 2022